Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125729961 | 12572996 | 1 | I | 200803 | 20090317 | 20160720 | 20160720 | PER | US-ASTRAZENECA-2009BM14762 | ASTRAZENECA | 607.00 | MON | F | Y | 156.00000 | KG | 20160720 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125729961 | 12572996 | 1 | PS | SYMLIN | PRAMLINTIDE ACETATE | 1 | Subcutaneous | 21332 | 60 | UG | INJECTION | TID | |||||||
125729961 | 12572996 | 2 | SS | SYMLIN | PRAMLINTIDE ACETATE | 1 | Subcutaneous | SYMLIN 120, 120UG THREE TIMES A DAY | 21332 | INJECTION | |||||||||
125729961 | 12572996 | 3 | SS | SYMLIN | PRAMLINTIDE ACETATE | 1 | Subcutaneous | 21332 | 120 | UG | INJECTION | TID | |||||||
125729961 | 12572996 | 4 | SS | SYMLIN | PRAMLINTIDE ACETATE | 1 | Subcutaneous | SYMLIN 120, 120UG THREE TIMES A DAY | A0801001 | 21332 | INJECTION | ||||||||
125729961 | 12572996 | 5 | SS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 0 | 2 | MG | /wk | ||||||||
125729961 | 12572996 | 6 | SS | LISINOPRIL HCTZ | HYDROCHLOROTHIAZIDELISINOPRIL | 1 | Oral | 20/1.2 MG DAILY | 0 | TABLET | |||||||||
125729961 | 12572996 | 7 | C | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | Oral | 50/1000 MG DAILY | 0 | ||||||||||
125729961 | 12572996 | 8 | C | DUETACT | GLIMEPIRIDEPIOGLITAZONE HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125729961 | 12572996 | 1 | Type 2 diabetes mellitus |
125729961 | 12572996 | 2 | Type 2 diabetes mellitus |
125729961 | 12572996 | 3 | Type 2 diabetes mellitus |
125729961 | 12572996 | 4 | Type 2 diabetes mellitus |
125729961 | 12572996 | 5 | Glycosylated haemoglobin decreased |
125729961 | 12572996 | 6 | Hypertension |
125729961 | 12572996 | 7 | Type 2 diabetes mellitus |
125729961 | 12572996 | 8 | Type 2 diabetes mellitus |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125729961 | 12572996 | Dizziness | |
125729961 | 12572996 | Intentional product misuse | |
125729961 | 12572996 | Nausea | |
125729961 | 12572996 | Nodule | |
125729961 | 12572996 | Weight decreased | |
125729961 | 12572996 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125729961 | 12572996 | 1 | 200803 | 200903 | 0 | |
125729961 | 12572996 | 2 | 200901 | 200902 | 0 | |
125729961 | 12572996 | 3 | 200901 | 200902 | 0 | |
125729961 | 12572996 | 4 | 200902 | 0 | ||
125729961 | 12572996 | 5 | 20160506 | 0 | ||
125729961 | 12572996 | 6 | 2006 | 0 | ||
125729961 | 12572996 | 7 | 2011 | 0 |